142 related articles for article (PubMed ID: 28673428)
21. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G
Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus associated with a post-transplant lymphoproliferative disorder presenting as isolated gastrointestinal tract bleeding.
Badham K; Mirchandani A; Arumainayagam N; West DR
Endoscopy; 2007 Feb; 39 Suppl 1():E64-5. PubMed ID: 17323282
[No Abstract] [Full Text] [Related]
23. T-cell LPD of the GIT: first do no harm.
Said J
Blood; 2013 Nov; 122(22):3548-50. PubMed ID: 24263952
[TBL] [Abstract][Full Text] [Related]
24. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.
McElroy MK; Read WL; Harmon GS; Weidner N
Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278
[TBL] [Abstract][Full Text] [Related]
25. Gastric post transplant lymphoproliferative disorder in a cytomegalovirus positive live related renal allograft recipient: a single case study.
Gupta P; Solanki A; Krishnani N
Indian J Pathol Microbiol; 2012; 55(3):416-8. PubMed ID: 23032851
[No Abstract] [Full Text] [Related]
26. Present nosography of lymphoproliferative disorders.
Raphael M; Binet JL
Acta Haematol; 1987; 78 Suppl 1():142-5. PubMed ID: 2893505
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
28. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
29. Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy.
Takahashi N; Tsukasaki K; Kohri M; Akuzawa Y; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
J Clin Exp Hematop; 2020; 60(1):7-10. PubMed ID: 32224564
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.
Tiede C; Maecker-Kolhoff B; Klein C; Kreipe H; Hussein K
Transplantation; 2013 Feb; 95(3):479-88. PubMed ID: 23296147
[TBL] [Abstract][Full Text] [Related]
31. The chronic proliferative disease of large granular lymphocytes.
Bassan R; Rambaldi A; Barbui T
Haematologica; 1989; 74(1):85-94. PubMed ID: 2498190
[TBL] [Abstract][Full Text] [Related]
32. Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease.
Weiss LM; Wood GS; Trela M; Warnke RA; Sklar J
N Engl J Med; 1986 Aug; 315(8):475-9. PubMed ID: 3488502
[TBL] [Abstract][Full Text] [Related]
33. Indolent NK-cell lymphoproliferative disorder of the GI tract: a rare indolent neoplasm of the GI tract.
Attieh M; Asakrah S
Blood; 2023 Apr; 141(16):2033. PubMed ID: 37079328
[No Abstract] [Full Text] [Related]
34. [Successful treatment with L-asparaginase-based combination chemotherapy for refractory T-cell post-transplant lymphoproliferative disorder].
Mihara A; Chen CK; Yokoyama K; Ueda T; Tsukada Y; Awaya N; Mori T; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2007 Apr; 48(4):305-9. PubMed ID: 17515121
[TBL] [Abstract][Full Text] [Related]
35. Metronomic chemotherapy for indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.
Liu H; Cao L; Zhao X; Miao Y; Wu W; Shi X; Zhang X; Yin H; Zhu H; Xu W; Li J; Fan L
Cancer Sci; 2023 Sep; 114(9):3793-3796. PubMed ID: 37340510
[TBL] [Abstract][Full Text] [Related]
36. [Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract with the whole wall involvement: report of a case].
Huang WY; Zeng L; Liao SS; Zhang W; Liu FR; Li LX; Huang YH
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1051-1053. PubMed ID: 36207926
[TBL] [Abstract][Full Text] [Related]
37. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.
Yang F; Li Y; Braylan R; Hunger SP; Yang LJ
Pediatr Blood Cancer; 2008 Feb; 50(2):415-8. PubMed ID: 17051534
[TBL] [Abstract][Full Text] [Related]
38. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
[No Abstract] [Full Text] [Related]
39. Biologic and clinical heterogeneity of lymphoproliferative diseases of peripheral mature T lymphocytes.
Pandolfi F; Zambello R; Cafaro A; Semenzato G
Lab Invest; 1992 Sep; 67(3):274-302. PubMed ID: 1405488
[No Abstract] [Full Text] [Related]
40. Asymptomatic post-transplant lymphoproliferative disorder diagnosed at one year protocol renal allograft biopsy.
Kitajima K; Sasaki H; Koike J; Nakazawa R; Sato Y; Yazawa M; Tsuruoka K; Kawarazaki H; Imai N; Shirai S; Shibagaki Y; Chikaraishi T
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():42-4. PubMed ID: 24842822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
